Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EY India data integrity survey flags gaps, missing processes

This article was originally published in Scrip

Executive Summary

An EY (formerly Ernst & Young) survey around data integrity compliance issues within the Indian pharmaceutical sector has thrown up some potentially worrisome findings, including an absence of quality processes and procedures at some firms amid work pressure and manpower shortages.

Advertisement

Related Content

Data Integrity Failures Undermine Trust That Can’t Easily Be Won Back, EMA Official Says
Data Integrity Lapses Continue To Erode Wockhardt
Does India's Perpetual Licensing Plan Risk Backfiring?
India's Risk-Based Inspection Plan: Well Begun?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC028904

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel